Karolinska Development AB (publ) (FRA:2I9)

Germany flag Germany · Delayed Price · Currency is EUR
0.0019
-0.0022 (-53.66%)
Last updated: Jan 28, 2026, 8:15 AM CET
-97.32%
Market Cap17.88M -23.1%
Revenue (ttm)157.20K -7.5%
Net Income-12.28M
EPS-0.05
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0019
Previous Close0.0041
Day's Range0.0019 - 0.0019
52-Week Range0.0019 - 0.0850
Betan/a
RSI38.61
Earnings DateFeb 13, 2026

About Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 8
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2I9
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements